Memphis Pharmaceuticals (MPCI.CA) - Company's Response to the Central Auditing Organization Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010 Reuters Code : MPCI.CA Content : Company's response to the Central Auditing Organization Report for the financial statements for the period ended on 31/12/2021. The Company's Response (559 KB) |
Comments